FMP
HCW Biologics Inc.
HCWB
NASDAQ
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The company was incorporated in 2018 and is headquartered in Miramar, Florida.
1.53 USD
-0.13 (-8.5%)
About
ceo
Dr. Hing C. Wong Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.hcwbiologics.com
exchange
NASDAQ
Description
HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as pulmonary fibrosis; and HCW9302 for auto-immune diseases, such as alopecia areata and metabolic diseases. It also develops HCW9201, a cell-based therapy that is in Phase II clinical trials for the treatment of patients with relapsed/refractory acute myeloid leukemia; and HCW9206 for the treatment of acute myeloid leukemia. The com...
CIK
0001828673
ISIN
US40423R1059
CUSIP
40423R105
Address
2929 North Commerce Parkway
Phone
954 842 2024
Country
US
Employee
45
IPO Date
Jul 20, 2021
Summary
CIK
0001828673
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
40423R105
ISIN
US40423R1059
Country
US
Price
1.53
Beta
0.97
Volume Avg.
16k
Market Cap
57.87M
Shares
-
52-Week
0.91-2.32
DCF
-0.18
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-2.19
P/B
-
Website
https://www.hcwbiologics.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest HCWB News
It looks like there's no news available.
